DOCSLIB.ORG

Series Fungal Infections 3 Pulmonary and Sinus Fungal Diseases in Non

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Series Fungal Infections 3 Pulmonary and Sinus Fungal Diseases in Non Series Fungal infections 3 Pulmonary and sinus fungal diseases in non-immunocompromised patients David W Denning, Arunaloke Chakrabarti The human respiratory tract is exposed daily to airborne fungi, fungal enzymes, and secondary metabolites. The Lancet Infect Dis 2017 endemic fungi Histoplasma capsulatum, Coccidioides spp, Blastomyces dermatitidis, and Paracoccidioides brasiliensis, and Published Online occasionally Aspergillus fumigatus, are primary pulmonary pathogens of otherwise healthy people. Such infections July 31, 2017 resolve in most people, and only a few infections lead to disease. However, many fungi are directly allergenic by http://dx.doi.org/10.1016/ S1473-3099(17)30309-2 colonising the respiratory tract or indirectly through contact with cell wall constituents and proteases, causing or See Online/Series exacerbating allergic disease. Increasing evidence implicates high indoor fungal exposures as a precipitant of asthma http://dx.doi.org/10.1016/ in children and in worsening asthma symptoms. Lung or airways infection by endemic fungi or aspergillus can be S1473-3099(17)30303-1, diagnosed with respiratory sample culture or serum IgG testing. Sputum, induced sputum, or bronchial specimens http://dx.doi.org/10.1016/ are all suitable specimens for detecting fungi; microscopy, fungal culture, galactomannan antigen, and aspergillus S1473-3099(17)30304-3, http://dx.doi.org/10.1016/ PCR are useful tests. Antifungal treatment is indicated in almost all patients with chronic cavitary pulmonary S1473-3099(17)30306-7, infections, chronic invasive and granulomatous rhinosinusitis, and aspergillus bronchitis. Most patients with fungal http://dx.doi.org/10.1016/ asthma benefit from antifungal therapy. Adverse reactions to oral azoles, drug interactions, and azole resistance in S1473-3099(17)30316-X, Aspergillus spp limit therapy. Environmental exposures, genetic factors, and structural pulmonary risk factors probably http://dx.doi.org/10.1016/ S1473-3099(17)30442-5, underlie disease but are poorly understood. http://dx.doi.org/10.1016/ S1473-3099(17)30443-7, and Introduction Fungal rhinosinusitis can be classified into four broad http://dx.doi.org/10.1016 Different species of fungi are inhaled; some are capable of clinical presentations:4 immunocompromised, an acute S1473-3099(17)30308-0 surviving at body temperature and evading the host invasive phenotype with fulminant course; mild or no See Online/Comment http://dx.doi.org/10.1016/ defences of healthy individuals. A very small number of discernible impairment of immunity, a chronic invasive S1473-3099(17)30319-5 the fungi that cause pulmonary infection are true or granulomatous phenotype with a chronic course; This is the third in a Series of pathogens—the most notable are those pathogens that colonisation of nasal passage and sinus, a fungal ball eight papers about fungal cause endemic mycoses: Coccidioides spp, Histoplasma spp, phenotype with a chronic course; and atopic or genetic infections Blastomyces dermatitidis, and Paracoccidioides brasiliensis.1 susceptible host, eosinophil-related fungal rhinosinusitis Global Action Fund for Fungal Other pathogens, such as Aspergillus spp and Cryptococcus including allergic fungal rhinosinusitis with chronic or Infections, Geneva, Switzerland (Prof D W Denning FRCP); and spp, can overwhelm innate defences when inhaled in occasionally acute course. The National Aspergillosis substantial quantities or when patients have defects in the Fungi can be present on nasal mucosa of any healthy Centre, University Hospital innate immunity. Most of these defects are subtle and person and invade the mucous membrane in of South Manchester, poorly understood. immunocompromised patients and patients with chronic The University of Manchester, 5 Manchester Academic Health In this Series paper, we introduce the common fungal invasive disease. Science Centre, Manchester, UK diseases of the upper and lower airways in non- (Prof D W Denning); and immunocompromised patients, their prevalence, the Chronic invasive or granulomatous fungal rhinosinusitis Department of Medical clinical and radiological presentation, the mode of Whether chronic invasive rhinosinusitis and granu- Microbiology, Postgraduate Institute of Medical Education diagnosis, and therapy options (figure 1). Rare lomatous fungal rhinosinusitis are separate diseases or & Research, Chandigarh, India manifestations of these infections are not addressed in different presentations of the same phenotype is unclear. (A Chakrabarti MD) depth. We also explore some less well understood issues Chronic invasive fungal rhinosinusitis is seen worldwide Correspondence to: about the presentation of fungal exposure in buildings or in patients with diabetes or who are on steroid therapy, Prof David Denning, through occupation. whereas the granulomatous type is seen in apparently The National Aspergillosis Centre, University Hospital of healthy people in a geographically confined region South Manchester, the University Fungal rhinosinusitis between Sudan and India. Abundant hyphae with mixed of Manchester, Manchester Fungal rhinosinusitis is now more commonly recognised inflammation and isolation of Aspergillus fumigatus are Academic Health Science Centre, 4,6 Manchester M23 9LT, UK and is somewhat controversially separated into different hallmarks of chronic invasive fungal rhinosinusitis. [email protected] phenotypes, each with a separate treatment strategy. Dematiaceous fungi, including Alternaria spp and About 10% of the adult population has chronic Curvularia spp, are occasionally isolated. In granu- rhinosinusitis,2 a proportion of which are various types of lomatous fungal rhinosinusitis, Aspergillus flavus is the fungal rhinosinusitis, which means that many millions most common species indicated, and hyphae are sparse of people are affected.3 A dysfunctional interplay between in tissue and usually present inside giant cells. Both the human host and fungi at the nasal and sinus mucosa diseases have a chronic course with marked orbital results in a wide range of clinical presentations.3 involvement. Diagnosis is established by histopathology www.thelancet.com/infection Published online July 31, 2017 http://dx.doi.org/10.1016/S1473-3099(17)30309-2 1 Series Paracoccidioidomycosis Disseminated Chronic cavitary Histoplasmosis Disseminated Chronic cavitary Acute Cryptococcosis Pneumonia Pneumonia Coccidioidomycosis Miliary/ Chronic cavitary Primary/ dissemanated nodule Valley fever Blastomycosis Disseminated Acute Chronic cavitary/ Acute Invasive Bronchitis Fungal asthma Aspergillosis nodule/aspergillma/ Community- ABPA chronic fibrosing acquired Immune status and underlying pulmonary disease Neutropenia T-cell dysfunction COPD Normal lungs CGD Corticosteroids Sarcoidosis Bronchiectasis Asthma No overt immune Allogeneic HSCT AIDS/HIV Rheumatoid arthritis Airways damage Cystic fibrosis deficit Lung cancer Solid organ transplant Pneumothorax Figure 1: Spectrum of pulmonary fungal disease and mycoses Aspergillosis affects a broad range of patients. Aspergillosis and cryptococcosis occur worldwide, whereas endemic mycoses are geographically confined. The coloured boxes represent groups of underlying diseases, with the more classical immunocompromising diseases to the left. ABPA=allergic bronchopulmonary aspergillosis. HSCT=haematopoetic stem-cell transplant. COPD=chronic obstructive pulmonary disease. CGD=chronic granulomatous disease. of endoscopically removed samples and culture. IgG Patients present with symptoms of chronic sinusitis, antibodies to aspergillus or precipitins can be useful in which might include facial pressure, headache, nasal monitoring therapy.7 Management consists of surgical stuffiness, and discharge.18 Patients often have a history of debridement, preferably endoscopically, and antifungal multiple surgeries and incomplete responses to therapy. Amphotericin B, itraconazole, or voriconazole antibacterial therapy; allergic fungal rhinosinusitis should for 6–12 weeks are effective post-debridement.8–10 be suspected in intractable sinusitis with nasal polyposis. Some patients present with proptosis. CT scans of the Fungal ball sinuses will reveal opacification with concretions or Fungi colonise the sinus mucosa and produce a dense calcifications, or both. Positive type 1 hypersensitivity is conglomeration of hyphae in one sinus cavity, most common, and the presence of eosinophilic mucin typically the maxillary sinus but occasionally the containing fungal hyphae is diagnostic. Dematiaceous sphenoid sinus.6 The disease occurs worldwide but is fungi including Alternaria, Bipolaris, and Curvularia spp most prevalent in elderly women in southern France.11,12 are often isolated from patients in developed countries. By Management consists of endoscopic removal.4 Antifungal contrast, A flavus is isolated from patients in south Asia, therapy is not necessary for maxillary fungal ball but can the Middle East, and Sudan. be advisable post-operatively for patients with disease in The cornerstones of infection management are removal the sphenoid sinus.13 of nasal polyps combined with topical cortico steroids immediately after surgery, short-term antibiotic therapy Allergic fungal rhinosinusitis for concurrent bacterial infection (notably for Akin to allergic bronchopulmonary aspergillosis, a Staphylococcus aureus),19 and nasal irrigation with saline. profound Th2 lymphocyte response with eosinophilic Relapse is common but can be prevented, in part, mucin in the sinus is the hallmark of
Load more

Recommended publications
  • Calcium Affects Polyphosphate and Lipid Accumulation in Mucoromycota Fungi
    Journal of Fungi Article Calcium Affects Polyphosphate and Lipid Accumulation in Mucoromycota Fungi Simona Dzurendova 1,*, Boris Zimmermann 1 , Achim Kohler 1, Kasper Reitzel 2 , Ulla Gro Nielsen 3 , Benjamin Xavier Dupuy--Galet 1 , Shaun Leivers 4 , Svein Jarle Horn 4 and Volha Shapaval 1 1 Faculty of Science and Technology, Norwegian University of Life Sciences, Drøbakveien 31, 1433 Ås, Norway; [email protected] (B.Z.); [email protected] (A.K.); [email protected] (B.X.D.–G.); [email protected] (V.S.) 2 Department of Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark; [email protected] 3 Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark; [email protected] 4 Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Christian Magnus Falsens vei 1, 1433 Ås, Norway; [email protected] (S.L.); [email protected] (S.J.H.) * Correspondence: [email protected] or [email protected] Abstract: Calcium controls important processes in fungal metabolism, such as hyphae growth, cell wall synthesis, and stress tolerance. Recently, it was reported that calcium affects polyphosphate and lipid accumulation in fungi. The purpose of this study was to assess the effect of calcium on the accumulation of lipids and polyphosphate for six oleaginous Mucoromycota fungi grown under different phosphorus/pH conditions. A Duetz microtiter plate system (Duetz MTPS) was used for the cultivation. The compositional profile of the microbial biomass was recorded using Fourier-transform infrared spectroscopy, the high throughput screening extension (FTIR-HTS).
    [Show full text]
  • Estimated Burden of Serious Fungal Infections in Ghana
    Journal of Fungi Article Estimated Burden of Serious Fungal Infections in Ghana Bright K. Ocansey 1, George A. Pesewu 2,*, Francis S. Codjoe 2, Samuel Osei-Djarbeng 3, Patrick K. Feglo 4 and David W. Denning 5 1 Laboratory Unit, New Hope Specialist Hospital, Aflao 00233, Ghana; [email protected] 2 Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, P.O. Box KB-143, Korle-Bu, Accra 00233, Ghana; [email protected] 3 Department of Pharmaceutical Sciences, Faculty of Health Sciences, Kumasi Technical University, P.O. Box 854, Kumasi 00233, Ghana; [email protected] 4 Department of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, Ghana; [email protected] 5 National Aspergillosis Centre, Wythenshawe Hospital and the University of Manchester, Manchester M23 9LT, UK; [email protected] * Correspondence: [email protected] or [email protected] or [email protected]; Tel.: +233-277-301-300; Fax: +233-240-190-737 Received: 5 March 2019; Accepted: 14 April 2019; Published: 11 May 2019 Abstract: Fungal infections are increasingly becoming common and yet often neglected in developing countries. Information on the burden of these infections is important for improved patient outcomes. The burden of serious fungal infections in Ghana is unknown. We aimed to estimate this burden. Using local, regional, or global data and estimates of population and at-risk groups, deterministic modelling was employed to estimate national incidence or prevalence. Our study revealed that about 4% of Ghanaians suffer from serious fungal infections yearly, with over 35,000 affected by life-threatening invasive fungal infections.
    [Show full text]
  • Ecology of Histoplasma Casulatum Var. Capsulatum
    Vaccines & Vaccination Open Access Ecology of Histoplasma Casulatum var. Capsulatum Pal M* Editorial Founder of Narayan Consultancy on Veterinary Public Health and Microbiology, India Volume 2 Issue 1 Received Date: July 22, 2017 *Corresponding author: Mahendra Pal, Founder of Narayan Consultancy on Published Date: July 29, 2017 Veterinary Public Health and Microbiology, 4 Aangan, Jagnath Ganesh Dairy Road, Anand-388001, India, Tel: 091-9426085328; Email: [email protected] Editorial Ecology is defined as the study of an organism in Since the first recognition of Histoplasma capsulatum relation to its environment. Most of the fungi such as in 1905 by Darling, three varieties of this dimorphic Aspergillus fumigatus, Blastomyces dermatitidis, fungus are described. These are H. capsulatum var. Cryptococcus neoformans, Fusrium solani, Geotrichum capsulatum (American histoplasmosis), H. capsulatum var. candidum, Histoplasma capsulatum, Sprothrix schenckii duboisii (African histolasmosis, affects man and baboon) etc., have ecological association with environmental and H. capsulatum var. farciminosum. The later variety substrates. These mycotic agents are frequently causes epizootic lymphangitis in animals mainly in recovered from the soil, avian droppings, bat guano, equines. It is a major fungal disease of equines in Ethiopia. woods, litter, sewage, straw, vegetables, fruits and other Among these varieties, H.casulatum var. capsulatum, plant materials. Among these saprophytic fungi, commonly known as H. capsulatum, is global in Histoplasma capsulatum is an important dimorphic distribution, and causes infections in humans as well as in fungus, which can cause life threatening disease in many species of animals such as bat, bear, cat, cattle, dog, humans and in a wide variety of animals. The recorded ferret, fox, horse, monkey, sheep etc.
    [Show full text]
  • Coccidioides Immitis
    24/08/2017 FUNGAL AGENTS CAUSING INFECTION OF THE LUNG Microbiology Lectures of the Respiratory Diseases Prepared by: Rizalinda Sjahril Microbiology Department Faculty of Medicine Hasanuddin University 2016 OVERVIEW OF CLINICAL MYCOLOGY . Among 150.000 fungi species only 100-150 are human pathogens 25 spp most common pathogens . Majority are saprophyticLiving on dead or decayed organic matter . Transmission Person to person (rare) SPORE INHALATION OR ENTERS THE TISSUE FROM TRAUMA Animal to person (rare) – usually in dermatophytosis 1 24/08/2017 OVERVIEW OF CLINICAL MYCOLOGY . Human is usually resistant to infection, unless: Immunoscompromised (HIV, DM) Serious underlying disease Corticosteroid/antimetabolite treatment . Predisposing factors: Long term intravenous cannulation Complex surgical procedures Prolonged/excessive antibacterial therapy OVERVIEW OF CLINICAL MYCOLOGY . Several fungi can cause a variety of infections: clinical manifestation and severity varies. True pathogens -- have the ability to cause infection in otherwise healthy individuals 2 24/08/2017 Opportunistic/deep mycoses which affect the respiratory system are: Cryptococcosis Aspergillosis Zygomycosis True pathogens are: Blastomycosis Seldom severe Treatment not required unless extensive tissue Coccidioidomycosis destruction compromising respiratory status Histoplasmosis Or extrapulmonary fungal dissemination Paracoccidioidomycosis COMMON PATHOGENS OBTAINED FROM SPECIMENS OF PATIENTS WITH RESPIRATORY DISEASE Fungi Common site of Mode of Infectious Clinical
    [Show full text]
  • 1 COVID-19 Pandemic: Staged Management of Surgical Services
    COVID-19 Pandemic: Staged Management of Surgical Services for Gynecology and Obstetrics Emily E. WEBER LEBRUN, MD, MS; Nash S. MOAWAD, MD, MS; E I. ROSENBERG, MD, Timothy E. MOREY, MD; Laurie Davies, MD; William O. COLLINS, MD; and John C. SMULIAN, MD, MPH Emily E. WEBER LEBRUN, MD, MS University of Florida College of Medicine, Department of Obstetrics & Gynecology Nash S. MOAWAD, MD, MS University of Florida College of Medicine, Department of Obstetrics & Gynecology Eric I. ROSENBERG, MD University of Florida College of Medicine, Department of Medicine Timothy E. MOREY, MD University of Florida College of Medicine, Department of Anesthesiology Laurie Davies, MD University of Florida College of Medicine, Department of Anesthesiology William O. COLLINS, MD University of Florida College of Medicine, Department of Otolaryngology John C. SMULIAN, MD, MPH University of Florida College of Medicine, Department of Obstetrics & Gynecology Acknowledgements: We would like to acknowledge the thoughtful contributions of Islam MD, Brian Hoh MD, Brent Carr MD, Jeffrey White MD, Laurie Davies MD and Parker Gibbs MD, all from the University of Florida College of Medicine without compensation. Disclosures: The authors have no relevant conflicts of interest or financial disclosures. Word Count: Abstract 168; Text 2043 1 Condensation: During the COVID-19 pandemic, a staged reduction in gynecologic and obstetric surgical services is needed to protect patients and the healthcare workforce, conserve personal protective equipment, and allow redeployment of facility resources. Short Title: Staged Surgical Postponement during COVID-19 Pandemic ABSTRACT: The COVID-19 pandemic has required an unprecedented global healthcare response requiring maintenance of existing hospital-based services while simultaneously preparing for high-acuity care for infected and sick individuals.
    [Show full text]
  • A Comparative Study of Pneumomediastinums Based on Clinical Experience
    ORIGINAL ARTICLE A comparative study of pneumomediastinums based on clinical experience Ersin Sapmaz, M.D.,1 Hakan Işık, M.D.,1 Deniz Doğan, M.D.,2 Kuthan Kavaklı, M.D.,1 Hasan Çaylak, M.D.1 1Department of Thoracic Surgery, Gülhane Training and Research Hospital, Ankara-Turkey 2Department of Pulmonology, Gülhane Training and Research Hospital, Ankara-Turkey ABSTRACT BACKGROUND: Pneumomediastinum (PM) is the term which defines the presence of air in the mediastinum. PM has also been described as mediastinal emphysema. PM is divided into two subgroups called as Spontaneous PM (SPM) and Secondary PM (ScPM). METHODS: A retrospective comparative study of the PM diagnosed between February 2010 and July 2018 is presented. Forty patients were compared. Clinical data on patient history, physical characteristics, symptoms, findings of examinations, length of the hospital stay, treatments, clinical time course, recurrence and complications were investigated carefully. Patients with SPM, Traumatic PM (TPM) and Iatrogenic PM (IPM) were compared. RESULTS: SPM was identified in 14 patients (35%). In ScPM group, TPM was identified in 16 patients (40%), and IPM was identified in 10 patients (25%). On the SPM group, the most frequently reported symptoms were chest pain, dyspnea, subcutaneous emphysema and cough. CT was performed to all patients to confirm the diagnosis and to assess the possible findings. All patients prescribed pro- phylactic antibiotics to prevent mediastinitis. CONCLUSION: The present study aimed to evaluate the clinical differences and managements of PMs in trauma and non-trauma patients. The clinical spectrum of pneumomediastinum may vary from benign mediastinal emphysema to a fatal mediastinitis due to perforation of mediastinal structures.
    [Show full text]
  • Cryptococcus Neoformans</Em>
    Clemson University TigerPrints All Dissertations Dissertations December 2019 Role of Cryptococcus neoformans Pyruvate Decarboxylase and Aldehyde Dehydrogenase Enzymes in Acetate Production and Virulence Mufida Ahmed Nagi Ammar Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations Recommended Citation Ammar, Mufida Ahmed Nagi, "Role of Cryptococcus neoformans Pyruvate Decarboxylase and Aldehyde Dehydrogenase Enzymes in Acetate Production and Virulence" (2019). All Dissertations. 2488. https://tigerprints.clemson.edu/all_dissertations/2488 This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by an authorized administrator of TigerPrints. For more information, please contact [email protected]. Role of Cryptococcus neoformans Pyruvate Decarboxylase and Aldehyde Dehydrogenase Enzymes in Acetate Production and Virulence A Dissertation Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy Biochemistry and Molecular Biology by Mufida Ahmed Nagi Ammar December 2019 Accepted by: Dr. Kerry Smith, Committee Chair Dr. Julia Frugoli Dr. Cheryl Ingram-Smith Dr. Lukasz Kozubowski ABSTRACT The basidiomycete Cryptococcus neoformans is is an invasive opportunistic pathogen of the central nervous system and the most frequent cause of fungal meningitis. C. neoformans enters the host by inhalation and protects itself from immune assault in the lungs by producing hydrolytic enzymes, immunosuppressants, and other virulence factors. C. neoformans also adapts to the environment inside the host, including producing metabolites that may confer survival advantages. One of these, acetate, can be kept in reserve as a carbon source or can be used to weaken the immune response by lowering local pH or as a key part of immunomodulatory molecules.
    [Show full text]
  • Tuberculosis Mediastinal Fibrosis Misdiagnosed As Chronic Bronchitis for 10 Years: a Case Report
    1183 Letter to the Editor Tuberculosis mediastinal fibrosis misdiagnosed as chronic bronchitis for 10 years: a case report Wei-Wei Gao, Xia Zhang, Zhi-Hao Fu,Wei-Yi Hu, Xiang-Rong Zhang, Guang-Chuan Dai, Yi Zeng Department of Tuberculosis of Three, Nanjing Public Health Medical Center, Nanjing Second Hospital, Nanjing Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing 211132, China Correspondence to: Dr. Yi Zeng. Department of Tuberculosis of Three, Nanjing Public Health Medical Center, Nanjing Second Hospital, Nanjing Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, No. 1, Kangfu Road, Nanjing 211132, China. Email: [email protected]. Submitted Feb 27, 2019. Accepted for publication Jun 19, 2019. doi: 10.21037/qims.2019.06.13 View this article at: http://dx.doi.org/10.21037/qims.2019.06.13 Background over previous 2 months. All vital signs at presentation were normal (temperature: 37.6 , heart rate: 97/min, blood Mediastinal fibrosis (MF, or fibrosing mediastinitis) is a rare pressure: 155/95 mmHg, saturation: 95%). Clinical physical condition characterized by rapid increase of fibrous tissues in ℃ examination revealed a lip purpura and reduced breath the mediastinum and is often associated with granulomatous sound in the right lung. diseases such as histoplasmosis, tuberculosis, sarcoidosis, and other fibroinflammatory and autoimmune diseases (1-3). It can cause compression and obliteration of vital mediastinal Laboratory tests structures, e.g., trachea, esophagus, and great vessels (4,5). Blood test results were as follows: blood cell count and Given that the disease is rare and its clinical symptoms liver and kidney function normal.
    [Show full text]
  • Turning on Virulence: Mechanisms That Underpin the Morphologic Transition and Pathogenicity of Blastomyces
    Virulence ISSN: 2150-5594 (Print) 2150-5608 (Online) Journal homepage: http://www.tandfonline.com/loi/kvir20 Turning on Virulence: Mechanisms that underpin the Morphologic Transition and Pathogenicity of Blastomyces Joseph A. McBride, Gregory M. Gauthier & Bruce S. Klein To cite this article: Joseph A. McBride, Gregory M. Gauthier & Bruce S. Klein (2018): Turning on Virulence: Mechanisms that underpin the Morphologic Transition and Pathogenicity of Blastomyces, Virulence, DOI: 10.1080/21505594.2018.1449506 To link to this article: https://doi.org/10.1080/21505594.2018.1449506 © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group© Joseph A. McBride, Gregory M. Gauthier and Bruce S. Klein Accepted author version posted online: 13 Mar 2018. Submit your article to this journal Article views: 15 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=kvir20 Publisher: Taylor & Francis Journal: Virulence DOI: https://doi.org/10.1080/21505594.2018.1449506 Turning on Virulence: Mechanisms that underpin the Morphologic Transition and Pathogenicity of Blastomyces Joseph A. McBride, MDa,b,d, Gregory M. Gauthier, MDa,d, and Bruce S. Klein, MDa,b,c a Division of Infectious Disease, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792, USA; b Division of Infectious Disease, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, 1675 Highland Avenue, Madison, WI 53792, USA; c Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, 1550 Linden Drive, Madison, WI 53706, USA.
    [Show full text]
  • Antifungals for Onychomycosis & Systemic Infections
    Clinical Policy: Infectious Disease Agents: Antifungals for Onychomycosis & Systemic Infections Reference Number: OH.PHAR.PPA.70 Effective Date: 01/01/2020 Last Review Date: N/A Coding Implications Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description: INFECTIOUS DISEASE AGENTS: AGENTS FOR ONYCHOMYCOSIS NO PA REQUIRED “PREFERRED” PA REQUIRED “NON-PREFERRED” GRIFULVIN®V tablets (griseofulvin, microsize) ITRACONAZOLE (generic of Sporanox®) GRISEOFULVIN suspension (generic of LAMISIL Granules (terbinafine) Grifulvin®V) ONMEL® (itraconazole) GRIS-PEG® (griseofulvin, ultramicrosize) SPORANOX® 100mg/10ml oral solution TERBINAFINE (generic of Lamisil®) (itraconazole) INFECTIOUS DISEASE AGENTS: AGENTS FOR SYSTEMIC INFECTIONS NO PA REQUIRED “PREFERRED” PA REQUIRED “NON-PREFERRED” FLUCONAZOLE (generic of Diflucan®) CRESEMBA® (isavuconazonium) FLUCONAZOLE suspension (generic of ITRACONAZOLE capsules (generic of Diflucan®) Sporanox®) FLUCYTOSINE (generic of Ancobon®) NOXAFIL® (posaconazole) KETOCONAZOLE (generic of Nizoral®) ORAVIG® (miconazole) SPORANOX® 100mg/10ml oral solution (itraconazole) VORICONAZOLE (generic of Vfend®) TOLSURA (itraconazole) FDA Approved Indication(s): Antifungals are indicated for the treatment of: • aspergillosis • blastomycosis • bone and joint infections • candidemia • candidiasis • candidiasis prophylaxis • candiduria • cryptococcal meningitis • cryptococcosis • cystitis Page 1 of 9 CLINICAL POLICY Infectious Disease Agents:
    [Show full text]
  • Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990–2015 Elizabeth M
    Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990–2015 Elizabeth M. Brown,1 Lisa R. McTaggart,1 Deirdre Dunn, Elizabeth Pszczolko, Kar George Tsui, Shaun K. Morris, Derek Stephens, Julianne V. Kus,2 Susan E. Richardson2 In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate. For CME questions, see page 1400. Release date: June 15, 2018; Expiration date: June 15, 2019 Learning Objectives Upon completion of this activity, participants will be able to: • Describe the epidemiology and geographic distribution of microbiology laboratory-confirmed
    [Show full text]
  • Fungal Sinusitis Clinical Presentation, Latest Management: a Review Update
    www.banglajol.info/index.php/JSF Journal of Science Foundation, January 2014, Vol. 12, No.1 ISSN 1728-7855 Review Article Fungal sinusitis clinical presentation, latest management: A Review Update Bithi Bhowmik1 Abstract Fungal sinusitis is a relatively common, often misdiagnosed disease process involving the paranasal sinuses. It is a serious condition, as certain forms of fungal sinusitis are associated with a high rate of mortality. Successful treatment requires a prompt diagnosis and frequently relies on radiologic imaging, specifically computed tomography (CT) and magnetic resonance (MR) imaging. The classification of fungal sinusitis is ever changing, but under the most current and widely accepted classification fungal sinusitis is broadly categorized as either invasive or noninvasive. Invasive fungal sinusitis is defined by the presence of fungal hyphae within the mucosa, submucosa, bone, or blood vessels of the paranasal sinuses. Invasive fungal sinusitis is subdivided into acute invasive fungal sinusitis, chronic invasive fungal sinusitis, and chronic granulomatous invasive fungal sinusitis. Conversely, noninvasive fungal sinusitis is defined by the absence of hyphae within the mucosal and other tissues of the paranasal sinuses. Noninvasive fungal sinusitis is subdivided into allergic fungal sinusitis and fungus ball (fungal mycetoma).[Journal of Science Foundation, 2014;12(1):16-19] Keywords: Fungal sinusitis; clinical presentation; management 1.0. Introduction Chronic sinusitis is a very common problem , and occurs even more frequently in people with allergies. A large number of people with chronic sinusitis are actually suffering from fungal sinus infections, which would not get better with typical antibiotics (Ferguson et al., 2000). Fungal infections of the sinuses have recently been blamed for causing most cases of chronic rhinosinusitis.
    [Show full text]